品牌 |
产品目录号 |
产品名称 |
产品规格 |
产品目录价 |
产品类型 |
链接 |
|||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BIOXCELL |
CP014-1MG |
RecombiMAb anti-mouse LAG-3
RecombiMAb anti-mouse LAG-3
|
1 mg |
5824.00 |
Recombinant Primary Antibody |
||||||||||||||||||||||||||||||||||||||||||
BIOXCELL |
CP013-25MG |
RecombiMAb anti-mouse LAG-3 (D265A)
RecombiMAb anti-mouse LAG-3 (D265A)
|
25 mg |
78847.60 |
Recombinant Primary Antibody |
||||||||||||||||||||||||||||||||||||||||||
BIOXCELL |
CP013-5MG |
RecombiMAb anti-mouse LAG-3 (D265A)
RecombiMAb anti-mouse LAG-3 (D265A)
|
5 mg |
22573.20 |
Recombinant Primary Antibody |
||||||||||||||||||||||||||||||||||||||||||
BIOXCELL |
CP013-1MG |
RecombiMAb anti-mouse LAG-3 (D265A)
RecombiMAb anti-mouse LAG-3 (D265A)
|
1 mg |
5824.00 |
Recombinant Primary Antibody |
||||||||||||||||||||||||||||||||||||||||||
BIOXCELL |
CP008-25MG |
RecombiMAb anti-mouse CTLA-4 (CD152) (LALA-PG)
RecombiMAb anti-mouse CTLA-4 (CD152) (LALA-PG)
|
25 mg |
78847.60 |
Recombinant Primary Antibody |
||||||||||||||||||||||||||||||||||||||||||
BIOXCELL |
CP008-5MG |
RecombiMAb anti-mouse CTLA-4 (CD152) (LALA-PG)
RecombiMAb anti-mouse CTLA-4 (CD152) (LALA-PG)
|
5 mg |
22573.20 |
Recombinant Primary Antibody |
||||||||||||||||||||||||||||||||||||||||||
BIOXCELL |
CP008-1MG |
RecombiMAb anti-mouse CTLA-4 (CD152) (LALA-PG)
RecombiMAb anti-mouse CTLA-4 (CD152) (LALA-PG)
|
1 mg |
5824.00 |
Recombinant Primary Antibody |
||||||||||||||||||||||||||||||||||||||||||
BIOXCELL |
CP007-25MG |
RecombiMAb anti-mouse CTLA-4 (CD152)
RecombiMAb anti-mouse CTLA-4 (CD152)
|
25 mg |
78847.60 |
Recombinant Primary Antibody |
||||||||||||||||||||||||||||||||||||||||||
BIOXCELL |
CP007-5MG |
RecombiMAb anti-mouse CTLA-4 (CD152)
RecombiMAb anti-mouse CTLA-4 (CD152)
|
5 mg |
22573.20 |
Recombinant Primary Antibody |
||||||||||||||||||||||||||||||||||||||||||
BIOXCELL |
CP007-1MG |
RecombiMAb anti-mouse CTLA-4 (CD152)
RecombiMAb anti-mouse CTLA-4 (CD152)
|
1 mg |
5824.00 |
Recombinant Primary Antibody |
||||||||||||||||||||||||||||||||||||||||||
BIOXCELL |
CP006-25MG |
RecombiMAb anti-mouse CTLA-4 (CD152)
RecombiMAb anti-mouse CTLA-4 (CD152)
|
25 mg |
78847.60 |
Recombinant Primary Antibody |
||||||||||||||||||||||||||||||||||||||||||
BIOXCELL |
CP006-5MG |
RecombiMAb anti-mouse CTLA-4 (CD152)
RecombiMAb anti-mouse CTLA-4 (CD152)
|
5 mg |
22573.20 |
Recombinant Primary Antibody |
||||||||||||||||||||||||||||||||||||||||||
BIOXCELL |
CP006-1MG |
RecombiMAb anti-mouse CTLA-4 (CD152)
RecombiMAb anti-mouse CTLA-4 (CD152)
|
1 mg |
5824.00 |
Recombinant Primary Antibody |
||||||||||||||||||||||||||||||||||||||||||
BIOXCELL |
CP005-25MG |
RecombiMAb anti-mouse PD-1 (CD279) (D265A)
RecombiMAb anti-mouse PD-1 (CD279) (D265A)
|
25 mg |
78847.60 |
Recombinant Primary Antibody |
||||||||||||||||||||||||||||||||||||||||||
BIOXCELL |
CP005-5MG |
RecombiMAb anti-mouse PD-1 (CD279) (D265A)
RecombiMAb anti-mouse PD-1 (CD279) (D265A)
|
5 mg |
22573.20 |
Recombinant Primary Antibody |
||||||||||||||||||||||||||||||||||||||||||
BIOXCELL |
CP005-1MG |
RecombiMAb anti-mouse PD-1 (CD279) (D265A)
RecombiMAb anti-mouse PD-1 (CD279) (D265A)
|
1 mg |
5824.00 |
Recombinant Primary Antibody |
||||||||||||||||||||||||||||||||||||||||||
BIOXCELL |
CP002-25MG |
RecombiMAb anti-mouse PD-1 (CD279) (D265A)
RecombiMAb anti-mouse PD-1 (CD279) (D265A)
|
25 mg |
78847.60 |
Recombinant Primary Antibody |
||||||||||||||||||||||||||||||||||||||||||
BIOXCELL |
CP002-5MG |
RecombiMAb anti-mouse PD-1 (CD279) (D265A)
RecombiMAb anti-mouse PD-1 (CD279) (D265A)
|
5 mg |
22573.20 |
Recombinant Primary Antibody |
||||||||||||||||||||||||||||||||||||||||||
BIOXCELL |
CP002-1MG |
RecombiMAb anti-mouse PD-1 (CD279) (D265A)
RecombiMAb anti-mouse PD-1 (CD279) (D265A)
|
1 mg |
5824.00 |
Recombinant Primary Antibody |
||||||||||||||||||||||||||||||||||||||||||
BIOXCELL |
CP001-25MG |
RecombiMAb anti-mouse PD-L1 (B7-H1) (D265A)
RecombiMAb anti-mouse PD-L1 (B7-H1) (D265A)
|
25 mg |
78847.60 |
Recombinant Primary Antibody |
||||||||||||||||||||||||||||||||||||||||||
BIOXCELL |
CP001-5MG |
RecombiMAb anti-mouse PD-L1 (B7-H1) (D265A)
RecombiMAb anti-mouse PD-L1 (B7-H1) (D265A)
|
5 mg |
22573.20 |
Recombinant Primary Antibody |
||||||||||||||||||||||||||||||||||||||||||
BIOXCELL |
CP001-1MG |
RecombiMAb anti-mouse PD-L1 (B7-H1) (D265A)
RecombiMAb anti-mouse PD-L1 (B7-H1) (D265A)
|
1 mg |
5824.00 |
Recombinant Primary Antibody |
||||||||||||||||||||||||||||||||||||||||||
BIOXCELL |
BP0366-100MG |
InVivoPlus mouse IgG2c isotype control, anti-dengue virus
InVivoPlus mouse IgG2c isotype control, anti-dengue virus
|
100 mg |
62925.20 |
Isotype Control |
||||||||||||||||||||||||||||||||||||||||||
BIOXCELL |
BP0366-50MG |
InVivoPlus mouse IgG2c isotype control, anti-dengue virus
InVivoPlus mouse IgG2c isotype control, anti-dengue virus
|
50 mg |
44486.00 |
Isotype Control |
||||||||||||||||||||||||||||||||||||||||||
BIOXCELL |
BP0366-25MG |
InVivoPlus mouse IgG2c isotype control, anti-dengue virus
InVivoPlus mouse IgG2c isotype control, anti-dengue virus
|
25 mg |
29556.80 |
Isotype Control |
||||||||||||||||||||||||||||||||||||||||||
BIOXCELL |
BP0366-5MG |
InVivoPlus mouse IgG2c isotype control, anti-dengue virus
InVivoPlus mouse IgG2c isotype control, anti-dengue virus
|
5 mg |
8824.40 |
Isotype Control |
||||||||||||||||||||||||||||||||||||||||||
BIOXCELL |
BP0356-100MG |
InVivoPlus anti-mouse CD20
InVivoPlus anti-mouse CD20
|
100 mg |
62925.20 |
Primary Antibody |
||||||||||||||||||||||||||||||||||||||||||
BIOXCELL |
BP0356-50MG |
InVivoPlus anti-mouse CD20
InVivoPlus anti-mouse CD20
|
50 mg |
44486.00 |
Primary Antibody |
||||||||||||||||||||||||||||||||||||||||||
BIOXCELL |
BP0356-25MG |
InVivoPlus anti-mouse CD20
InVivoPlus anti-mouse CD20
|
25 mg |
29556.80 |
Primary Antibody |
||||||||||||||||||||||||||||||||||||||||||
BIOXCELL |
BP0356-5MG |
InVivoPlus anti-mouse CD20
InVivoPlus anti-mouse CD20
|
5 mg |
8824.40 |
Primary Antibody |
||||||||||||||||||||||||||||||||||||||||||